Contact:
Karen Whelan, Public Relations & Practice Marketing Specialist
508-787-1461
kwhelan@optos.com
Optos to Participate in ASCRS
4/26/2007
MARLBOROUGH, MA, April 26, 2007 – Optos, a leading medical technology company for the design, development, manufacturing, and marketing of retinal imaging devices, will host key educational activities at the American Society of Cataract and Refractive Surgery (ASCRS) taking place in San Diego, CA, April 27-May 1, 2007.
Optos will hold its Optos Academy meeting while at ASCRS on Sunday, April 29, 2007 from 6:00-7:30 am. A popular workshop series, the Optos Academy is for Partners and other interested doctors which will highlight techniques and best practices created to enable clinicians to achieve the highest level of success with Optos’ technology. Among the distinguished presenters are Robert Maloney, MD, Donald Digby, MD, and Anurag Gupta, MD.
"The optomap® Retinal Exam enables ophthalmologists to easily document retinal disease unlike any other modality on the market due to the widefield capabilities of the Panoramic200,” stated Dr. Maloney. "Our practice has found that the P200 enhances the overal experience for LASIK patients as it is a great tool for evaluating them for refractive surgery."
In addition, Optos will host “Meet the Expert Physician” presentations in its booth, #1125, which will highlight various topics such as: “Enhancing Your Patient’s Experience – the Value of the optomap® Retinal Exam to a Refractive Surgeon;” “Using the optomap® Retinal Exam and the optomap® plus Medical Retinal Exam in the Anterior Segment Practice;” and “Why the optomap® Retinal Exam Enhances Clinical and Business Success in a Premium Anterior Segment Practice – 3 Years and Counting.”
Representatives from Optos will be at its booth throughout ASCRS to meet with Optos Partners as well as educate interested attendees on Optos’ technology. Optos encourages attendees to stop by its booth to receive a complimentary optomap® Retinal Exam and learn how this innovative technology – used by more than 2,500 eye care practitioners worldwide – helps with the detection and diagnosis of both eye and non-eye related conditions.
Note to Editors
Optos plc is a leading and rapidly growing medical technology company for the design, development, manufacturing and marketing of devices that image the retina, the light-sensitive area at the back of the eye. Optos' platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image - branded the optomap® Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina, such as glaucoma, diabetic retinopathy and age-related macular degeneration.
The Company has gained regulatory clearance (CE and FDA 510(k)) to market a second device - P200MA. The P200MA is aimed at the specialist ophthalmic and medical as opposed to the primary care market. It is designed to produce an angiographic retinal image called optomap® fa that supports medical procedures by providing enhanced diagnostic, monitoring and treatment capabilities. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as diabetes, hypertension and certain cancers. Optos’ technology provides an unequalled combination of wide-field retinal imaging, speed and convenience for both practitioner and patient and can help save sight and save lives.
Optos estimates that its P200 device is targeting a recurring US$2 billion market opportunity. As at 30 September 2006 Optos had 232 employees serving more than 2,500 customers in the Company’s existing markets, currently the USA, Canada, UK and Germany. Optos plc is headquartered in Dunfermline, Scotland and was admitted to the Main Market of the London Stock Exchange on 15 February 2006 trading under the symbol OPTS.
Optos is incorporated in Scotland under the Companies Act 1985 with registered number SC139953. The Company maintains its Registered Office at Queensferry House, Carnegie Business Campus, Dunfermline, Scotland KY11 8GR United Kingdom.